Moderna

Forecast & Rating23 analysts currently cover Moderna, with about 21.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $121.00, about 38.4% downside from the current price of $196.48. Price targets range from $45.00 to $170.00 — a wide spread, showing clear disagreement over just how much Moderna can rise. Historically, about 55.1% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Moderna's outlook. Data as of Oct 7, 2026; for reference only and not investment advice.